JOHNSON DAVID EDWARD received a stock award from AMAG PHARMACEUTICALS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 6/4/2020ACC: 0000902664-20-002288
10% Owner
Since Aug 2019
+31.56K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
31.56K acquired
Non-Derivative Transactions1
Common Stock, par value $0.01 per share ("Common Stock")
Direct
Shares
+10.27K
Price / share
—
Trade value
—
% of position
233.0%
6/2/2020
4.41K→14.68K
Total
Net shares
+10.27K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock, par value $0.01 per share ("Common Stock") Direct | 6/2/2020 | A · Award | +10.27K | — | — | 233.0% | 4.41K | 14.68K |
| Total | +10.27K | $0.00 | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
21.29K shares
Shares
+21.29K
Strike price
8.52
Held after
21.29K
Exercisable
—
6/2/2020
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock21.29K shares | 6/2/2020 | A · Award | +21.29K | 8.52 | — | 21.29K |
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned3.50M
Total
3.50M indirect3.50M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 3.50M | Indirect |
| Total | 3.50M | 3.50M indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported